Literature DB >> 31939869

Estimated Number of Men Who Have Sex With Men With Indications for HIV Pre-exposure Prophylaxis in a National Sexual Network Study.

Kevin M Weiss1, Pragati Prasad, Ramya Ramaraju, Maria Zlotorzynska, Samuel M Jenness.   

Abstract

BACKGROUND: A 2015 CDC analysis estimated that 24.7% of sexually active men who have sex with men (MSM) had indications for HIV pre-exposure prophylaxis (PrEP) based on 2014 US Public Health Service (USPHS) clinical practice guidelines. Given that the USPHS revised these guidelines in 2017, updated estimates of the fraction of MSM indicated for PrEP overall and stratified by demographic factors and geography are needed to scale-up PrEP for MSM in the US.
METHODS: We conducted a national web-based study of 4904 MSM aged 15-65 who had ever had sex with another man between July 2017 and January 2019. We estimated the percentage of HIV-negative, sexually active MSM meeting USPHS indications for PrEP by demographic category.
RESULTS: Of 3511 sexually active, HIV-negative MSM, 34.0% (95% confidence interval: 32.4 to 35.6) met USPHS indications for PrEP, with percentages consistent across US census region and varying slightly by race/ethnicity (Black: 32.2%, White: 33.7%, Hispanic: 36.4%, Other: 33.6%). Among individuals meeting USPHS PrEP indications, 93.5% reported condomless anal intercourse in the prior 6 months. Among all survey respondents, PrEP eligibility was lowest among non-Hispanic black (18.4%) and younger respondents (15-17: 4.1%; 18-24: 18.1%).
CONCLUSIONS: Estimated percentages of MSM meeting indications for PrEP exceeded the previous CDC estimate across race/ethnicity, age, and census regions, with one-third of adult, sexually active, HIV-negative MSM exhibiting indications for PrEP. This study suggests, given current guidelines for PrEP indications, that a different fraction of eligible MSM could be receiving PrEP than previously estimated.

Entities:  

Mesh:

Year:  2020        PMID: 31939869      PMCID: PMC7140979          DOI: 10.1097/QAI.0000000000002300

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  36 in total

1.  Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States.

Authors:  Samuel M Jenness; Steven M Goodreau; Eli Rosenberg; Emily N Beylerian; Karen W Hoover; Dawn K Smith; Patrick Sullivan
Journal:  J Infect Dis       Date:  2016-07-14       Impact factor: 5.226

2.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Authors:  Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

3.  Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.

Authors:  Hsiu Wu; Maria C B Mendoza; Ya-Lin A Huang; Tameka Hayes; Dawn K Smith; Karen W Hoover
Journal:  Clin Infect Dis       Date:  2016-10-19       Impact factor: 9.079

4.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

5.  Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England.

Authors:  Holly D Mitchell; Sarika Desai; Hamish Mohammed; Koh Jun Ong; Martina Furegato; Victoria Hall; Monica Desai; John Michael Saunders; Gwenda Hughes; Nigel Field; O Noel Gill
Journal:  Sex Transm Infect       Date:  2019-04-22       Impact factor: 3.519

6.  Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.

Authors:  Patrick S Sullivan; Robertino Mera Giler; Farah Mouhanna; Elizabeth S Pembleton; Jodie L Guest; Jeb Jones; Amanda D Castel; Howa Yeung; Michael Kramer; Scott McCallister; Aaron J Siegler
Journal:  Ann Epidemiol       Date:  2018-06-22       Impact factor: 3.797

7.  Sources of racial disparities in HIV prevalence in men who have sex with men in Atlanta, GA, USA: a modelling study.

Authors:  Steven M Goodreau; Eli S Rosenberg; Samuel M Jenness; Nicole Luisi; Sarah E Stansfield; Gregorio A Millett; Patrick S Sullivan
Journal:  Lancet HIV       Date:  2017-04-18       Impact factor: 12.767

8.  Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System.

Authors:  Julia L Marcus; Leo B Hurley; C Bradley Hare; Michael J Silverberg; Jonathan E Volk
Journal:  Am J Public Health       Date:  2016-10       Impact factor: 9.308

9.  Bacterial Sexually Transmitted Infection Screening Rates by Symptomatic Status Among Men Who Have Sex With Men in the United States: A Hierarchical Bayesian Analysis.

Authors:  Samuel M Jenness; Kevin M Weiss; Pragati Prasad; Maria Zlotorzynska; Travis Sanchez
Journal:  Sex Transm Dis       Date:  2019-01       Impact factor: 2.830

10.  Racial/Ethnic Disparities in HIV Preexposure Prophylaxis Among Men Who Have Sex with Men - 23 Urban Areas, 2017.

Authors:  Dafna Kanny; William L Jeffries; Johanna Chapin-Bardales; Paul Denning; Susan Cha; Teresa Finlayson; Cyprian Wejnert
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-09-20       Impact factor: 17.586

View more
  2 in total

1.  Updated Estimates of the Number of Men Who Have Sex With Men (MSM) With Indications for HIV Pre-exposure Prophylaxis.

Authors:  Laurel Bates; Amanda Honeycutt; Sarah Bass; Timothy A Green; Paul G Farnham
Journal:  J Acquir Immune Defic Syndr       Date:  2021-12-01       Impact factor: 3.771

Review 2.  Partnership dynamics in mathematical models and implications for representation of sexually transmitted infections: a review.

Authors:  Darcy White Rao; Margo M Wheatley; Steven M Goodreau; Eva A Enns
Journal:  Ann Epidemiol       Date:  2021-04-28       Impact factor: 6.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.